House
Create account
Drug reference directory
Drug reference

nirsevimab-alip

Monoclonal antibody (for RSV prevention)

Monoclonal antibody (for RSV prevention)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated

Mechanism

Nirsevimab-alip is a human monoclonal antibody that targets the prefusion form of the RSV F protein.

Related guidelines

Stroke and TIA — secondary prevention
AHA · Neurology · 2021
Tobacco-related cancer prevention
ICMR · Oncology · 2021
Cardiovascular disease prevention
ESC · Cardiology · 2021
Primary prevention of cardiovascular disease
AHA · Cardiology · 2019
Infective endocarditis prevention
ADA_DENTAL · Dentistry · 2015

Other Unclassified drugs

5-9-tetrahydrocannabinol
0 brands
6-mercaptopurine
0 brands
acetylsalicylic acid
0 brands
acotiamide
0 brands
acoziborole
0 brands
activated charcoal
0 brands
adrenaline
0 brands
adrenochrome monosemicarbazone
0 brands

Ask House about nirsevimab-alip

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspaceAsk House about this drug

Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10